Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Kedudukan dalam Saham #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Harga Saham
$29.06
Disegerakkan terakhir: 2023-02-23
Modal Pasaran
$682.73M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan CinCor Pharma, Inc. (CINC)

Kategori

Sejarah pecahan saham untuk CinCor Pharma, Inc. (CINC)
Saham CinCor Pharma, Inc. (simbol: CINC) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 30, 2026.
Satu saham CINC yang dibeli sebelum Aug 30, 2026 kini bersamaan dengan 0 saham CINC.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH